A Retrospective Analysis of nab-Paclitaxel as First-Line Therapy for Metastatic Breast Cancer Patients With Poor Prognostic Factors. - O'Shaughnessy, J.; Gradishar, W.; Bhar, P.; Iglesias, J. (Cancer Research, 2012)